首站-论文投稿智能助手
典型文献
Inactivation of tumor suppressor TAp63 by hepatitis B virus X protein in hepatocellular carcinoma
文献摘要:
Background::The hepatitis B virus X (HBx) protein plays a critical role in the initiation and progression of hepatitis B virus (HBV)-associated hepatocellular carcinoma (HCC). In the early stage of the disease, HBx facilitates tumor onset by inactivating the tumor suppressor p53. The p53-encoding gene, however, is frequently mutated or deleted as the cancer progresses to the late stage and, under such circumstance, the p53 homolog TAp63 can harness HCC growth by transactivating several important p53-target genes.Methods::To determine whether HBx regulates TAp63, we performed co-immunoprecipitation assay, real-time quantitative polymerase chain reaction, immunoblotting, and flow cytometry analysis in p53-null cancer cell lines, Hep3B and H1299.Results::HBx interacts with the transactivation domain of TAp63, as HBx was co-immunoprecipitated with TAp63 but not with ΔNp63. The interaction between HBx and TAp63 abolished transcriptional activity of TAp63, as evidenced by the reduction of the levels of its target genes p21 and PUMA, consequently leading to restricted apoptosis and augmented proliferation of HCC cells. Conclusion::HBV induces progression of HCC that harbors defective p53 by inhibiting the tumor suppressor TAp63.
文献关键词:
TAp63;hepatitis B virus X;Apoptosis;Proliferation;Liver cancer
作者姓名:
Xie Bangxiang;Hao Qian;Zhou Xiang;Chen Dexi
作者机构:
Beijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China;Beijing Engineering Research Center for Precision Medicine and Transformation of Hepatitis and Liver Cancer, Beijing 100069, China;Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, China;Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China
引用格式:
[1]Xie Bangxiang;Hao Qian;Zhou Xiang;Chen Dexi-.Inactivation of tumor suppressor TAp63 by hepatitis B virus X protein in hepatocellular carcinoma)[J].中华医学杂志(英文版),2022(14):1728-1733
A类:
transactivating,immunoprecipitated,Np63
B类:
Inactivation,tumor,suppressor,TAp63,by,hepatitis,virus,protein,hepatocellular,carcinoma,Background,HBx,plays,critical,role,initiation,progression,HBV,associated,HCC,early,stage,disease,facilitates,onset,inactivating,p53,encoding,however,frequently,mutated,deleted,cancer,progresses,under,such,circumstance,homolog,harness,growth,several,important,target,genes,Methods,To,determine,whether,regulates,performed,immunoprecipitation,assay,real,quantitative,polymerase,chain,reaction,immunoblotting,flow,cytometry,analysis,null,lines,Hep3B,H1299,Results,interacts,transactivation,domain,was,but,not,interaction,between,abolished,transcriptional,activity,evidenced,reduction,levels,its,p21,PUMA,consequently,leading,restricted,apoptosis,augmented,proliferation,cells,Conclusion,induces,that,harbors,defective,inhibiting,Apoptosis,Proliferation,Liver
AB值:
0.554233
相似文献
CircRNA.0007127 triggers apoptosis through the miR-513a-5p/CASP8 axis in K-562 cells
Xiajing LI;Yiyu ZHANG;Ning WANG;Zhaohu YUAN;Xiaojie CHEN;Qicong CHEN;Hui DENG;Xinxin TONG;Honglin CHEN;Yuyou DUAN;Yarning WEI-School of Medicine,South China University of Technology,Guangzhou 510000,China;Department of Blood Transfusion,Shenzhen Longhua Central Hospital,Shenzhen 518000,China;Laboratory of Stem Cells and Translational Medicine,Institutes for Life Sciences,School of Medicine,South China University of Technology,Guangzhou 510000,China;School of Biomedical Sciences and Engineering,Guangzhou International Campus,South China University of Technology,Guangzhou 510000,China;Department of Blood Transfusion,the Second Affiliation Hospital of South China University of Technology,Guangzhou 510000,China;Guangdong Engineering Research Center of Precise Transfusion,Guangzhou 510000,China
Globular adiponectin-mediated vascular remodeling by affecting the secretion of adventitial-derived tumor necrosis factor-αinduced by urotensin Ⅱ
Jun LI;Limin LUO;Yonggang ZHANG;Xiao DONG;Shuyi DANG;Xiaogang GUO;Wenhui DING-Department of Cardiology,the First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Division of Cardiology,Department of Internal Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,China;Division of Cardiology,Department of Internal Medicine,Peking University First Hospital,Beijing 100034,China;Department of Dermatology,the First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Department of Cardiovascular Diseases,the Second Affiliated Hospital,Shantou University Medical College,Shantou 515041,China
CUL4B facilitates HBV replication by promoting HBx stabilization
Haixia Shan;Bo Wang;Xiaodong Zhang;Hui Song;Xi Li;Yongxin Zou;Baichun Jiang;Huili Hu;Hao Dou;Changshun Shao;Lifen Gao;Chunhong Ma;Xiaoyun Yang;Xiaohong Liang;Yaoqin Gong-Key Laboratory for Experimental Teratology of the Ministry of Education,Key Laboratory of Infection and Immunity of Shandong Province and Department of Immunology,School of Basic Medical Sciences,Shandong University,Jinan 250012,China;Department of Laboratory Diagnosis,Cangzhou Combination of Traditional Chinese and Western Medicine Hospital of Hebei Province,Cangzhou 061000,China;Division of Gastroenterology and Hepatology,Renji Hospital,School of Medicine,Shanghai Jiao Tong University,Shanghai Institute of Digestive Disease,Shanghai 200120,China;Ministry of Education Key Laboratory of Experimental Teratology and Institute of Molecular Medicine and Genetics,School of Basic Medical Sciences,Shandong University,Jinan 250012,China;Collaborative Innovation Center of Technology and Equipment for Biological Diagnosis and Therapy in Universities of Shandong,Jinan 250012,China;Department of Gastroenterology,Qilu Hospital,Shandong University,Jinan 250012,China
IL13Rα1 prevents a castration resistant phenotype of prostate cancer by targeting hexokinase 2 for ubiquitin-mediated degradation
Tingting Feng;Jing Wang;Kai Cheng;Qiqi Lu;Ru Zhao;Shiguan Wang;Qingyun Zhang;Luna Ge;Jihong Pan;Guanhua Song;Lin Wang-Department of Pathology,School of Basic Medical Sciences,Shandong University,Jinan 250012,China;Department of Pathology,The Fourth People's Hospital of Jinan,Jinan 250031,China;Department of PET-CT,Shandong Cancer Hospital and Institute,Shandong First Medical University and Shandong Academy of Medical Sciences,Jinan 250002,China;The Second Hospital,Cheeloo College of Medicine,Shandong University Medical School,Jinan 250012,China;Biomedical Sciences College&Shandong Medicinal Biotechnology Centre,Key Lab for Biotech-Drugs of National Health Commission,Key Lab for Rare&Uncommon Diseases of Shandong Province,Shandong First Medical University&Shandong Academy of Medical Sciences,Jinan 250002,China;Department of Biochemistry and Molecular Biology,Shandong University School of Basic Medical Sciences,Jinan 250012,China;Institute of Basic Medicine,Shandong Academy of Medical Sciences,Shandong First Medical University&Shandong Academy of Medical Sciences,Jinan 250002,China;Department of Oncology,The First Affiliated Hospital of Shandong First Medical University,Jinan 250014,China
Serum mitochondrial tsRNA serves as a novel biomarker for hepatocarcinoma diagnosis
Shoubin Zhan;Ping Yang;Shengkai Zhou;Ye Xu;Rui Xu;Gaoli Liang;Chenyu Zhang;Xi Chen;Liuqing Yang;Fangfang Jin;Yanbo Wang-Nanjing Drum Tower Hospital Center of Molecular Diagnostic and Therapy,State Key Laboratory of Pharmaceutical Biotechnology and Department of Physiology,Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology,NJU Advanced Institute of Life Sciences(NAILS),School of Life Sciences,Nanjing University,Nanjing 210023,China;Department of Clinical Laboratory,The Affiliated Drum Tower Hospital of Nanjing University Medical School,Nanjing 210023,China;Department of Infectious Diseases,The First People's Hospital of Lianyungang,The First Affiliated Hospital of Kangda College of Nanjing Medical University,Lianyungang 222000,China;School of Medicine&Holistic Integrative Medicine,Nanjing University of Chinese Medicine,Nanjing 210023,China
Upregulation of wild-type p53 by small molecule-induced elevation of NQO1 in non-small cell lung cancer cells
Hong Yu;Hong-ying Gao;Hua Guo;Gui-zhen Wang;Yi-qing Yang;Qian Hu;Li-jun Liang;Qun Zhao;Da-wei Xie;Yu Rao;Guang-biao Zhou-School of Chinese Materia Medica,Beijing University of Chinese Medicine,Beijing 100029,China;State Key Laboratory of Molecular Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;MOE Key Laboratory of Protein Sciences,School of Pharmaceutical Sciences,MOE Key Laboratory of Bioorganic Phosphorus Chemistry&Chemical Biology,and School of Medicine and Collaborative Innovation Center of Biotherapy,Tsinghua University,Beijing 100084,China;Hubei University of Medicine,Shiyan 442000,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。